INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
53 hedge funds and large institutions have $3.1M invested in Infinity Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
83% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 18
Holders
53
Holding in Top 10
–
Calls
$22K
Puts
$8K
Top Buyers
| 1 | +$160K | |
| 2 | +$100K | |
| 3 | +$62.9K | |
| 4 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
+$27.5K |
| 5 |
VF
Virtu Financial
New York
|
+$17.4K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$735K | |
| 3 | -$672K | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$303K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$211K |